Vyome Holdings, Inc (HIND)

↓ Download CSV

CIK 0001427570 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Vyome Holdings, Inc reported revenue of $319.7K, up 24.4% from the prior year. The company ran a net loss, with a net margin of -3209.7% and a gross margin of 68.4%. It held $6.50M in total assets against $2.74M in total liabilities.

Key ratios (FY2025)

68.4%
Gross margin
-3269.4%
Operating margin
-3209.7%
Net margin
-272.8%
Return on equity
+24.4%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$319.7K$256.9K$9.10M$9.91M$3.39M
Cost of Revenue$100.9K$62.0K$3.13M$4.44M$5.25M$5.04M$2.95M
Gross Profit$218.8K$195.0K$5.55M$6.80M$8.35M$6.26M$331.0K$3.68M$5.08M$584.0K
Operating Income-$10.45M-$1.01M-$15.38M-$46.35M-$57.88M-$12.46M-$23.23M-$36.97M-$34.39M-$19.50M
Net Income-$10.26M-$1.45M-$11.39M-$46.21M-$63.15M-$21.63M-$23.68M-$37.38M-$34.77M-$20.47M
EPS (Diluted)$-4.86$-6001.39$-110.87$-108.90$-288.97$-5.54
Total Assets$6.50M$1.38M$10.66M$11.14M$52.53M$37.06M$20.39M$30.39M$53.10M$78.78M
Total Liabilities$2.74M$5.77M$4.00M$7.48M$8.20M$22.57M$4.54M$17.28M$17.99M$14.47M
Shareholders' Equity$3.76M-$4.39M-$6.17M$4.67M$15.85M$13.11M$35.11M$64.31M
Cash & Equivalents$4.98M$101.9K$4.46M$3.85M$22.77M$2.96M$14.05M$21.19M$21.11M$72.97M
Operating Cash Flow-$3.75M-$614.1K-$16.96M-$21.90M-$15.38M-$8.55M-$22.87M-$29.43M-$30.62M-$19.37M
Capital Expenditures$43.0K$131.0K$352.0K
Shares Outstanding5.92M0404.4K519.2K356.6K3.49M7.72M2.35M17.50M16.77M